Investigating the therapeutic potential of polymeric roflumilast nanosuspension in modulating asthma hallmarks using an in vivo ovalbumin model.

Saved in:
Bibliographic Details
Title: Investigating the therapeutic potential of polymeric roflumilast nanosuspension in modulating asthma hallmarks using an in vivo ovalbumin model.
Authors: Gulati N; Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, 124001, India., Paudel KR; NICM Health Research Institute and School of Science, Western Sydney University, Westmead, NSW, 2145, Australia.; Woolcock Institute of Medical Research, Macquarie University, NSW, Sydney, Australia., Dua K; NICM Health Research Institute and School of Science, Western Sydney University, Westmead, NSW, 2145, Australia.; Woolcock Institute of Medical Research, Macquarie University, NSW, Sydney, Australia., Dureja H; Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, 124001, India. harishdureja@mdurohtak.ac.in.; Centre for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura, 140401, Punjab, India. harishdureja@mdurohtak.ac.in.
Source: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2026 May; Vol. 399 (8), pp. 11515-11526. Date of Electronic Publication: 2026 Feb 19.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1912 (Electronic) Linking ISSN: 00281298 NLM ISO Abbreviation: Naunyn Schmiedebergs Arch Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-1912
DOI:10.1007/s00210-026-05112-3